Clinical Research

We produce research and build research capacity to increase the range of treatment options for people who use methamphetamine and emerging drugs.

Learn more

Current Research Projects

View all projects

Lisdexamfetamine for methamphetamine withdrawal (OLAM trial)

Oral Lisdexamfetamine for the treatment of Acute Methamphetamine withdrawal (the OLAM trial): A randomised controlled trial

Naltrexone-Bupropion for Methamphetamine Use Disorder (NABU)

An Open-Label Safety and Feasibility Pilot Trial of Oral Naltrexone-Bupropion Combination Pharmacotherapy for Methamphetamine Use Disorder

Ketamine-assisted psychotherapy for methamphetamine use disorder (KAPPA)

An open-label, safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder

Friday 22nd November

2024 NCCRED Symposium

The 2024 NCCRED Symposium discussed innovations within the alcohol and other drug sector which aim to improve the health outcomes for people who use methamphetamine and emerging drugs of concern.

Watch recordings

Latest webinars

Methamphetamine treatment: new and upcoming options

An update on new and upcoming treatment options for clinicians, researchers and people who use methamphetamine.

GHB Insights for service providers

The effects of GHB, its use in Australia, and harm reduction & treatment principles.

Methamphetamine: working with family and friends

How can we incorporate family and friends into treatment, and support them in their own right?

Emerging drugs resources

Webinars, videos, toolkits and reports to support clinicians to deliver better outcomes for people who use methamphetamine and emerging drugs.

View resources

Clinical practice meets clinical research